Insecticide Loaded Glyconanoparticle Formulation Service
Overview of Glyconanoparticle in Agriculture
Insecticides serve as a critical material foundation for defending against major agricultural pests and diseases, ensuring food security and agricultural productivity. Despite their importance, the effectiveness and safety of insecticides need further enhancement, largely due to factors such as wind, sunlight, rain, and pest resistance. The declining efficiency of insecticide use has led to increased formulations and crop losses, posing significant challenges to the sustainable control of pests and pathogens. Nonetheless, insecticides remain one of the most effective methods for controlling most plant diseases, providing indispensable benefits to crop production. Thus, enhancing the effectiveness and safety of chemical pesticides is essential for efficient pest management. Drawing from our extensive experience, CD BioGlyco provides insecticide-loaded glyconanoparticle formulation to improve utilization in the use of pesticide mixtures, which can reduce unnecessary large-scale and repetitive applications.
Smart Nanotech Formulations, Safeguarding the Harvest Path
Through our GlycoNano™ Platform, we utilize chitosan-based nanoparticles as carriers, which offer unique advantages such as high stability, biocompatibility, and the ability to enhance the efficacy of insecticides. These nanoparticles are specifically designed to encapsulate and deliver insecticides with precision, targeting harmful insects while minimizing environmental impact.
Synthesis of Insecticide-Loaded Chitosan Nanoparticles
We dissolve chitosan powder in an acetic acid solution with constant stirring using a magnetic stirrer. A solution of tripolyphosphate (TPP) containing the agrochemicals (spinosad and permethrin) is prepared. Add the agrochemical-TPP solution to the chitosan solution and stir continuously to form the nanoparticles. The suspension is centrifuged to separate the nanoparticles, which are then lyophilized to obtain the final product.
Characterization of Chitosan and Agrochemical Loaded Chitosan Nanoparticles
- We disperse the nanoparticles in water and analyze them using a UV-Vis spectrophotometer to confirm their formation and assess loading efficiency.
- By analyzing dried powdered samples through X-ray diffraction (XRD), we determine the crystalline structure and phase composition of the nanoparticles.
- Fourier Transform Infrared Spectroscopy (FT-IR) is used to obtain the infrared spectrum of the nanoparticles enabling us to identify functional groups and ensure the integrity of the chemical encapsulation.
- Field emission scanning electron microscopy (FE-SEM) is utilized to examine the surface morphology and particle size of the nanoparticles in detail.
- High-resolution transmission electron microscopy (HR-TEM) provides detailed structural information and verifies the uniformity of the nanoparticles.
- We disperse the nanoparticles in a solvent and analyze them to measure size distribution and surface charge, which are crucial for their stability and dispersion characteristics.
Analysis of Loading Efficiency
First, a chitosan solution is prepared by dissolving it in acetic acid with continuous stirring. Simultaneously, a solution of TPP containing the agrochemicals is prepared. The agrochemical-TPP solution is then added dropwise to the chitosan solution while stirring continuously to facilitate cross-linking. After mixing, the mixture is centrifuged to separate the nanoparticles, and the collected supernatant is analyzed using a UV-Vis spectrophotometer to measure its optical density (OD). This measurement is crucial for calculating the loading efficiency of the agrochemicals, and determining how much of the active ingredient is successfully encapsulated within the nanoparticles.
Release Rate Studies
The agrochemical-loaded chitosan nanoparticles are initially suspended in a Tris-HCl buffer solution. This suspension is then stirred continuously at a controlled temperature, and at specified intervals, the sample is centrifuged to separate the supernatant. The amount of agrochemicals released into the supernatant is subsequently measured using a UV-Vis spectrophotometer, providing critical data on the release profile and efficiency of the encapsulation process.
Biological Activity Analysis
We prepare chitosan and agrochemical-loaded chitosan nanoparticles, which we then apply to food vials to treat Drosophila melanogaster (fruit flies) in various assays. These assays include survivability, where we observe the number of eggs laid and hatched; climbing, where we measure the upward movement of the flies; and larval crawling, where we record the behavior and speed of third-instar larvae. We perform the experiments in triplicates and repeat them multiple times, calculating mean values and standard deviations. We use one-way ANOVA for statistical analysis to determine the significance of the results compared to control values. The overall aim of our work is to evaluate the effects of the nanoparticles on the survival, mobility, and behavior of fruit flies, providing insights into the potential impact of the agrochemical encapsulation on larval development and adult performance.
Workflow

Publication Data
Technology: Dynamic light scattering (DLS), Nanoparticle tracking analysis (NTA), High-performance liquid chromatography (HPLC), TEM, Atomic force microscopy (AFM)
DOI: 10.1038/s41598-018-26043-x
Journal: Scientific Reports
Published: 2016
IF: 3.8
Result: In this study, the authors developed and characterized chitosan nanoparticles functionalized with β-cyclodextrin for encapsulating the botanical insecticides carvacrol and linalool. The nanoparticles were fabricated using the emulsion/ionic gelation method. The research team assessed the physical properties, encapsulation efficiency, and in vitro release kinetics of the nanoparticles, and evaluated their bioactivity against specific pests, H. armigera and T. urticae. The study also assessed the cytotoxicity and phytotoxicity of the nanoparticles to ensure their safety. This work aimed to explore the potential of these nanoparticles for use in sustainable agricultural pest control, leveraging the benefits of nanotechnology with botanical compounds.
Applications
- Our service can be used to optimize resource utilization in precision agriculture for maximal yield.
- Our service is applied to developing highly efficient, and low-toxicity pesticides, providing more innovative solutions for the agricultural companies..
- Our service is useful for research to reduce pesticide residues on crops, enhancing food safety.
Advantages
- We encapsulate and deliver insecticides with precision, targeting harmful insects while minimizing environmental impact.
- Our formulations undergo rigorous field trials to validate their efficacy under real-world conditions.
- We offer customized glyconanoparticle formulations tailored to the specific pest control needs of different crops and regions.
Frequently Asked Questions
- Which insecticides can we load into glyconanoparticles?
Insecticide-loaded glyconanoparticle formulation Chlorpyrifos Hexazole alcohol Glyphosate Cypermethrin Avermectin Imidacloprid Trichlorfon Pyrethrin Citronella 2,4-Dsodiumsalt Lambda Cyhalothrin Permethrin Spinosad Rotenone Acetamiprid - What are the reasons for selecting nanomaterials as carriers?
Nanomaterials, characterized by their small size, large specific surface area, and modifiability, significantly enhance the adhesion of pesticides to both leaf surfaces and harmful target surfaces. This enhancement leads to improved efficiency by reducing the wastage attributable to coarse particles and imprecise release mechanisms. Additionally, it boosts the biological activity and overall efficacy of the pesticides.
CD BioGlyco offers diverse Glyconanoparticle Formulation Services and provides a comprehensive approach to the development and characterization of advanced insecticide-loaded glyconanoparticles, ensuring their effectiveness and safety in agricultural applications. If you are committed to enhancing overall ecosystem well-being and backing more sustainable agricultural methods, contact us today!
Reference
- Campos, E.V.; et al. Carvacrol and linalool co-loaded in β-cyclodextrin-grafted chitosan nanoparticles as sustainable biopesticide aiming pest control. Scientific Reports. 2018, 8(1): 7623.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




